At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 15 enrolled
Drug / intervention
lomitapidedrug
Likely dose
lomitapide 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1, Open-label, Crossover Study to Determine the Intra-subject Variability of the Pharmacokinetics of Single Oral CapsuleDose of 20 mg Lomitapide in Healthy Subjects
In Brief
A Phase 1 clinical trial evaluating lomitapide for Intra-subject Variability of Pharmacokinetics. Completed, enrolled 15 participants across 1 site.
Detailed Summary
Objectives: To evaluate the intra-subject variability of the pharmacokinetics (PK) of single oral capsule doses of 20 mg lomitapide.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom
Collaborators--
Timeline
Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJul 2013
First PostedAug 2013
Primary CompletionAug 2013
TodayJul 2026
First PostedAug 5, 2013
Enrollment StartJul 29, 2013
Primary CompletionAug 23, 2013
TodayJul 2, 2026
Enrollment to primary: 24 daysPosted 12.9 years ago
Interventions
lomitapidedrug
20 mg dose